フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Synairgen plc 17 January 2025 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
Synairgen plc 16 January 2025 Synairgen plc ('Synairgen' or the 'Company') Martin Murphy appointed as Non-Executive Director ...
Synairgen plc 16 January 2025 Synairgen plc ('Synairgen' or the 'Company') Result of General Meeting and Total Voting Rights ...
Synairgen plc 15 January 2025 Synairgen plc ('Synairgen' or the 'Company') £18 million raised to fund Phase 2 INVENT clinical trial of...
Synairgen plc 20 December 2024 THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) (THIS "ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS...
Synairgen plc 30 October 2024 Synairgen plc ('Synairgen' or the 'Company') Exercise of Share Options and Total Voting Rights ...
Synairgen plc 10 October 2024 Synairgen plc ('Synairgen' or the 'Company') Results of Annual General Meeting and Appointment of New...
The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported b ...
Synairgen plc 26 September 2024 Synairgen plc ('Synairgen' or the 'Company') Interim results for the six months ended 30 June 2024 ...
Synairgen plc 18 September 2024 Synairgen plc ('Synairgen' or the 'Company') Appointment of New Chairman Posting of Report and Accounts and...
Synairgen plc 05 September 2024 Synairgen plc ('Synairgen' or the 'Company') Board Change Southampton, UK - 5 September 2024: Synairgen...
outh Hampton, England-based drug discovery and development company focused on combatting respiratory disease - In 2023 ...
Synairgen plc 27 June 2024 Synairgen plc ('Synairgen' or the 'Company') Results for the year ended 31 December 2023 Southampton, UK - 27...
Synairgen plc 15 November 2023 Synairgen plc ('Synairgen' or the 'Company') Grant of Options Southampton, UK - 15 November...
outhampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infecti ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す